← Back to front page
United States · Exchanges & live quotes · Nasdaq

Calytrix Bio To Be Bought By Lilly In Up To $1.5 Bln Cash Deal

Published by Nasdaq · United States 44 min ago

Detailed summary

(RTTNews) - Calytrix Bio, Inc., a biotechnology company focused on myeloproliferative neoplasms or MPNs, announced Monday its definitive agreement to be acquired by drug major Eli…

Read the full article on Nasdaq Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.nasdaq.com)

Also worth reading